logo
logo
Search For Features
/
StocksStocks
Intraday BoosterIntraday Booster
Sector BoosterSector Booster
Stock ScreenerStock Screener
Market PulseMarket Pulse
ScreenersScreeners
MoreMore
prime iconGo Prime
My PlansMy Plans
Privacy PolicyPrivacy Policy
ContactContact
Refer & EarnRefer & Earn
ScreenersScreeners
Main
Stock ScreenerStock Screener
Create ScreenerCreate Screener
Explore ScreenersExplore Screeners
Community ScreenersCommunity Screeners
Trading Screeners
CandleSticks ScreenerCandleSticks Screener
Top Gainers & LosersTop Gainers & Losers
Opening Range BreakoutOpening Range Breakout
Stock Screener AIStock Screener AI
Stock Quality ScorecardStock Quality Scorecard
Overvalued StocksOvervalued StocksNew
Undervalued StocksUndervalued StocksNew
Technical Screeners
NR4 StocksNR4 Stocks
NR7 StocksNR7 Stocks
Previous Day High BreakoutPrevious Day High Breakout
Previous Day Low BreakoutPrevious Day Low Breakout
Previous Day Open BreakoutPrevious Day Open Breakout
Bullish Crossover StocksBullish Crossover Stocks
Bearish Crossover StocksBearish Crossover Stocks
High Volume ShockerHigh Volume Shocker
VWAP Breakout StocksVWAP Breakout Stocks
Range High BreakoutRange High Breakout
Range Low BreakoutRange Low Breakout
MoreMore
Markets
Global Market TodayGlobal Market Today
Global IndicesGlobal Indices
Indian IndicesIndian Indices
NIfty TodayNIfty Today
Smart Money
FII DII DataFII DII DataNew
FII BuyingFII Buying
NSE Insider TradingNSE Insider Trading
SLB Stocks DataSLB Stocks Data
Derivatives
FnO MovementsFnO Movements
NSE F&O Lot SizeNSE F&O Lot Size
Ban ListBan List
Analysis & Calendars
Technical DashboardTechnical Dashboard
Sector BoosterSector Booster
Sector AnalysisSector AnalysisNew
Result CalendarResult Calendar
Economic CalendarEconomic Calendar
TTK Healthcare Ltd

TTK Healthcare

Small Cap•1,508 Employees•IPO 2010
Current Price
₹850.15
-4.65 (-0.54%)Updated
NSE :TTKHLTCARE
BSE :507747
Sector :Pharmaceuticals
Valuation vs Sector
P/E Ratio
20.14vs 35.78
P/B Ratio
1.11vs 8.88
Div Yield
1.07%vs 1.66%
Today's Range
846.55
₹850.15
indicator
864.75
52 Week Range
52W Low₹846.50
52W High₹1398.90
₹850.15
indicator
Downside0.43%
Upside64.55%
chart iconChart

Price Chart

Compare with Peers

Historical Ratios

Track top 12 most important financial ratios

P/E Ratio: Price to Earnings - Most used valuation metric

Loading chart...

Analyzing Investment Quality

Processing 9 key metrics...

Key Metrics

Hover for details

Valuation

Market Cap
₹1,317.65 Cr
Market Cap
Total market value of company
P/E Ratio
21.94
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)
P/B Ratio
1.50
P/B Ratio
Price to Book Value. <3 may indicate undervaluation
EPS
₹42.51
EPS
Earnings Per Share. Higher and growing is positive

Profitability

ROE
3.40%
ROE
Return on Equity. >15% is good, >20% is excellent
ROCE
9.26%
ROCE
Return on Capital Employed. >15% is good
Net Margin
7.24%
Net Margin
Net profit as % of revenue. >10% is good
Operating Margin
-%
Operating Margin
Operating profit margin. >15% is good

Growth

EPS Growth (5Y)
45.91%
EPS Growth (5Y)
5-year EPS growth. >15% is strong
Revenue Growth (5Y)
4.42%
Revenue Growth (5Y)
5-year revenue growth. >10% is good
Qtr Sales Growth
2.56%
Qtr Sales Growth
Quarter-over-quarter sales growth
Qtr Profit Growth
18.60%
Qtr Profit Growth
Quarter-over-quarter profit growth

Financial Health

Debt/Equity
0.02
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellent
Book Value
₹753.73
Book Value
Net asset value per share
Dividend Yield
1.07%
Dividend Yield
Annual dividend as % of price. >2% is good
Promoter Holding
74.60%
Promoter Holding
Promoter stake. >50% shows confidence
Good
Average
Needs Attention

SWOT Analysis

Strengths

5 points
  • •High promoter holding of 74.6% indicates strong insider confidence and stability.
  • •Very low debt-to-equity ratio of 0.02 signifies a healthy financial structure.

Weaknesses

5 points
  • •Significant quarterly net profit volatility raises concerns about stable profitability.
  • •Low Return on Equity (ROE) of 3.40% indicates inefficient capital utilization.

Opportunities

5 points
  • •Diversified portfolio allows expansion into new product lines and emerging markets.
  • •Improving low operating profit margin (1.60%) can significantly boost profitability.

Threats

5 points
  • •Intense competition from higher ROCE peers threatens market share and profitability.
  • •High stock price volatility (₹1599 high, ₹991 low) poses significant investor risk.

Segment-wise Financial Analysis

Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...

Shareholding Pattern

Loading shareholding data...

Company Insider Trading Activity

No insider trading data available

Corporate Action

Company Announcements

Technical Analysis & Indicators

Standard pivot points - most widely used

Pivot Points (CLASSIC)

LevelPriceDistance% Change
R4₹897.48+₹47.33+5.57%
R3₹879.28+₹29.13+3.43%
R2₹872.02+₹21.87+2.57%
R1₹861.08+₹10.93+1.29%
PIVOT₹853.823.670.43%
CURRENT₹850.15--
S1₹806.48-₹43.67-5.14%
S2₹824.68-₹25.47-3.00%
S3₹835.62-₹14.53-1.71%
S4₹842.88-₹7.27-0.85%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: N/AP: N/ATC: N/A
R1
R2
R3
R4
indicator
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment

is trading CPR, indicating

● CPR Width

CPR is

● Opening Range

Day's range: ~

● Price Position

Trading Inside opening range

Delivery Volume Analysis & Trading Activity

Latest Volume
0.08L
(11 Mar 2026)
+55.5% vs avg
Delivery %
53.6%
(11 Mar 2026)
-17.6% vs avg
Avg Volume (20D)
0.05L
(11 Feb - 11 Mar)
20-day average
Avg Delivery %
71.1%
(11 Feb - 11 Mar)
Trend ↑
Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.

Peer Comparison & Industry Benchmarking

Quick Compare

Largest by Market Cap
Sun Pharmaceutical Industries Ltd
4.12L ₹ Cr
Best Profit Growth
Ind-Swift Laboratories Ltd
833.00 %
Highest Dividend Yield
Jagsonpal Pharmaceuticals Ltd
1.44 %

Peer Comparison

Company Name
AMRUTANJAN
Amrutanjan Health Care Ltd
BAJAJHCARE
Bajaj Healthcare Ltd
BETA
Beta Drugs Ltd
BLISSGVS
Bliss GVS Pharma Ltd
INDOCO
Indoco Remedies Ltd
INDSWFTLAB
Ind-Swift Laboratories Ltd
JAGSNPHARM
Jagsonpal Pharmaceuticals Ltd
LINCOLN
Lincoln Pharmaceuticals Ltd
NGLFINE
NGL Fine Chem Ltd
SAKAR
Sakar Healthcare Ltd
SIGACHI
Sigachi Industries Ltd
SMSPHARMA
SMS Pharmaceuticals Ltd
SUNPHARMA
Sun Pharmaceutical Industries Ltd
SYNCOMF
Syncom Formulations (India) Ltd
THEMISMED
Themis Medicare Ltd
VENUSREM
Venus Remedies Ltd

About

TTKHLTCARE

TTK Healthcare Ltd

TTK Healthcare Limited is a diversified Indian company operating across various sectors, including animal welfare, consumer products, medical devices, protective devices, food, and human pharmaceuticals. Its business model is segmented, allowing for focused growth and management within each area.

In the animal welfare segment, TTK Healthcare provides a comprehensive range of products for veterinarians and farmers, encompassing feed supplements, medications addressing various health concerns (liver support, fertility, infections, parasites), and specialized products for different animal types (dairy, poultry, aqua, pets). This signifies a substantial commitment to the animal health market in India.

The consumer products division markets and distributes a variety of goods under several well-established brand names. These include baby care products (Woodward's Gripewater), personal care and cosmetics (EVA), home care items (Good Home), and air fresheners, demonstrating a broad appeal to a large consumer base across various demographics.

Within the medical devices sector, TTK Healthcare is a significant player, notably producing and distributing artificial heart valves (TTK Chitra) and orthopedic implants and instruments crucial for knee and hip replacement surgeries. This high-value segment positions the company as a key contributor to India's healthcare infrastructure.

The protective devices segment focuses on sexual wellness products, including male contraceptives under the Skore brand. This specialization reveals a dedication to offering specific and important health solutions.

The foods division manufactures and markets food products such as papads (Fryums) and a range of cereal, potato, rice, pulse, and corn-based products. This broad portfolio taps into the everyday needs of a large portion of the Indian population.

In the human pharmaceuticals area, TTK Healthcare develops and commercializes medicines targeting various therapeutic areas, including gynecology, infertility, respiratory issues, orthopedics, cardiology, and general health. This reflects a dedication to addressing diverse healthcare requirements across a wide range of patient needs.

Finally, the 'Others' segment encompasses the printing and publishing of maps, atlases, guidebooks, and educational materials under the TTK brand. While distinct from the other segments, it showcases a diversification strategy beyond healthcare and related fields.

COMPANY FACTS - TTKHLTCARE

Registered Address

6, Cathedral Road

Chennai

TAMIL NADU

IN

Tel: 914428116108

Website:https://ttkhealthcare.com/

Investor Relations:http://ttkhealthcare.com/investors/
Company Details

Group: Pharmaceuticals, Biotechnology & Life Sciences

Sector: Health Care

Industry: Pharmaceuticals

Exchange: NATIONAL STOCK EXCHANGE OF INDIA

Employees: 1,508

IPO Date: 08/01/2010

MANAGEMENT - TTKHLTCARE

Mr. S. Kalyanaraman

Chief Executive Officer, Executive Director, Whole-Time Director

Shri. T. Raghunathan

Executive Vice Chairman of the Board

Mr. B. V. K. Durga Prasad

Chief Financial Officer, President - Finance

Ms. Gowry Jaishankar

Compliance Officer, Company Secretary

Dr. T T Mukund

Additional Non-Executive Non- independent Director

Mr. K. Shankaran

Non-Executive Director

Mr. R. K. Tulshan

Non-Executive Director

Mrs. Mrs. Anantkrishnan

Additional Independent Director

Mr. S. Balasubramanian

Non-Executive Independent Director

Mr. Ramesh Natarajan

Non-Executive Independent Director

Mr. Murali Neelakantan

Non-Executive Independent Director

Mr. V. Ranganathan

Non-Executive Independent Director

Investor Questions Answered

TTK Healthcare Ltd (TTKHLTCARE) Stock FAQs

Get answers to the most common questions about TTK Healthcare Ltd stock price, fundamentals, financial metrics, and investment analysis

The current share price of TTK Healthcare Ltd (TTKHLTCARE) is ₹850.15. Today, the stock has declined by ₹4.65 (0.54%), trading in a range of ₹846.55 to ₹864.75. The stock opened at ₹846.55 with a trading volume of 8,986 shares.
TTK Healthcare Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,317.65 crores, P/E ratio of 21.94, ROE of 3.40%, and ROCE of 9.26%. The dividend yield stands at 1.07%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of TTK Healthcare Ltd (TTKHLTCARE) is ₹1,398.9, while the 52-week low is ₹846.5. Currently trading at ₹850.15, the stock is 0.7% away from its 52-week low and 39.2% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy TTK Healthcare Ltd stock at ₹850.15 depends on multiple factors. The stock is currently trading with a P/E ratio of 21.94 and P/B ratio of N/A. Today's performance shows a loss of 0.54%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
TTK Healthcare Ltd offers a dividend yield of 1.07%, which means for every ₹100 invested at the current price of ₹850.15, you can expect to receive approximately ₹1.07 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
TTK Healthcare Ltd's key financial metrics include: P/E Ratio: 21.94, P/B Ratio: N/A, ROE: 3.40%, ROCE: 9.26%, Dividend Yield: 1.07%, EPS: ₹42.51, Book Value: ₹753.73, Debt-to-Equity: 0.02, and Current Ratio: N/A. The company's market cap stands at ₹1,317.65 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
TTK Healthcare Ltd stock opened at ₹846.55 and is currently trading at ₹850.15, showing a decline of ₹4.65 (0.54%). The intraday high is ₹864.75 and low is ₹846.55. The trading volume stands at 8,986 shares, indicating moderate market participation today.
TTK Healthcare Ltd has a Price-to-Earnings (P/E) ratio of 21.94, which means investors are willing to pay ₹21.94 for every ₹1 of earnings. With an EPS of ₹42.51, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
TTK Healthcare Ltd has a market capitalization of ₹1,317.65 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹850.15) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
TTK Healthcare Ltd has a book value of ₹753.73 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹850.15, which is 12.8% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
TTK Healthcare Ltd has a Return on Equity (ROE) of 3.40% and Return on Capital Employed (ROCE) of 9.26%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
TTK Healthcare Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
TTK Healthcare Ltd has a debt-to-equity ratio of 0.02, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
TTK Healthcare Ltd has an Earnings Per Share (EPS) of ₹42.51, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹850.15 and P/E ratio of 21.94, investors are paying 21.94 times the annual earnings per share. This moderate EPS suggests decent earnings generation. Track EPS growth over quarters to assess earnings momentum.
TTK Healthcare Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
TTK Healthcare Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze TTK Healthcare Ltd stock, consider: 1) Fundamental Analysis - Review P/E (21.94), ROE (3.40%), debt-to-equity (0.02), and growth rates. 2) Technical Analysis - Check 52-week range (₹846.50 - ₹1398.90), moving averages, and chart patterns. 3) Valuation - Compare current price (₹850.15) with book value (₹753.73) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of TTK Healthcare Ltd share is ₹10.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹850.15 is 8402x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in TTK Healthcare Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹846.50 - ₹1398.90). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.02 indicates leverage. 4) Liquidity Risk - Based on trading volume of 8,986 shares. 5) Valuation Risk - P/E of 21.94 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
TTK Healthcare Ltd operates in the industry with key metrics: P/E ratio of 21.94, ROE of 3.40%, market cap of ₹1,317.65 crores, and dividend yield of 1.07%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.02), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for TTK Healthcare Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹850.15, with a 52-week range of ₹846.50 to ₹1398.90. Based on fundamentals like P/E (21.94), ROE (3.40%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling TTK Healthcare Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹850.15. 2) Fundamental Deterioration - Declining ROE (currently 3.40%), increasing debt (D/E: 0.02), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for TTK Healthcare Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 1.07%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.